Sequence Variation at Two Eosinophil-Associated Ribonuclease Loci in Humans

Corresponding author: Helene F. Rosenberg, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bldg. 10, Rm. 11N104, 9000 Rockville Pike, Bethesda, MD 20892., hr2k{at}nih.gov (E-mail)

Communicating editor: S. YOKOYAMA

Host defense against invading pathogens is of great importance to the survival of higher organisms. We have been studying the evolution of mammalian eosinophil-associated ribonucleases (EARs), which are members of the ribonuclease A superfamily with known antipathogen activities. Earlier studies showed that positive selection promoted rapid diversification of paralogous EAR genes in both primates and rodents. Intraspecifically, however, it is unknown whether these genes also have divergent alleles. The recent discovery that the gene repertoire of the EAR family is much larger in rodents than in primates has led us to consider the possibility that primates maintain a large number of polymorphic alleles to compensate for a smaller gene repertoire. Here we present sequences of 2417 nucleotides at the two EAR loci, the eosinophil-derived neurotoxin (EDN, RNase 2) and eosinophil cationic protein (ECP, RNase 3), from >50 human individuals. Our data demonstrate that the nucleotide diversities (0.06–0.11%) at these loci are typical for human nuclear genes, thus permitting us to reject this polymorphism hypothesis. No significant departure from neutrality is noted and no signs of overdominant selection are observed. Similar patterns were observed in a preliminary study of chimpanzees. In summary, our results suggest that the antipathogen functions of the primate EARs are conserved after they are established and that these proteins are not currently undergoing rapid diversification in response to challenge from invading microorganisms.

This article has been cited by other articles:

				H. F. Rosenberg RNase A ribonucleases and host defense: an evolving story J. Leukoc. Biol., May 1, 2008; 83(5): 1079 - 1087. [Abstract] [Full Text] [PDF]

				J. Eriksson, C. Woschnagg, E. Fernvik, and P. Venge A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic protein J. Leukoc. Biol., December 1, 2007; 82(6): 1491 - 1500. [Abstract] [Full Text] [PDF]

				A. R. Rogers, S. Wooding, C. D. Huff, M. A. Batzer, and L. B. Jorde Ancestral Alleles and Population Origins: Inferences Depend on Mutation Rate Mol. Biol. Evol., April 1, 2007; 24(4): 990 - 997. [Abstract] [Full Text] [PDF]

				U.-B. Jonsson, J. Bystrom, G. Stalenheim, and P. Venge A (G->C) transversion in the 3' UTR of the human ECP (eosinophil cationic protein) gene correlates to the cellular content of ECP J. Leukoc. Biol., April 1, 2006; 79(4): 846 - 851. [Abstract] [Full Text] [PDF]

				T. Hayakawa, I. Aki, A. Varki, Y. Satta, and N. Takahata Fixation of the Human-Specific CMP-N-Acetylneuraminic Acid Hydroxylase Pseudogene and Implications of Haplotype Diversity for Human Evolution Genetics, February 1, 2006; 172(2): 1139 - 1146. [Abstract] [Full Text] [PDF]

				Y.-J. KIM, V. KUMARASWAMI, E. CHOI, J. MU, D. A. FOLLMANN, P. ZIMMERMAN, and T. B. NUTMAN GENETIC POLYMORPHISMS OF EOSINOPHIL-DERIVED NEUROTOXIN AND EOSINOPHIL CATIONIC PROTEIN IN TROPICAL PULMONARY EOSINOPHILIA Am J Trop Med Hyg, July 1, 2005; 73(1): 125 - 130. [Abstract] [Full Text] [PDF]

				L. O'Bryan, P. Pinkston, V. Kumaraswami, V. Vijayan, G. Yenokida, H. F. Rosenberg, R. Crystal, E. A. Ottesen, and T. B. Nutman Localized Eosinophil Degranulation Mediates Disease in Tropical Pulmonary Eosinophilia Infect. Immun., March 1, 2003; 71(3): 1337 - 1342. [Abstract] [Full Text] [PDF]

				E. Noguchi, A. Iwama, K. Takeda, T. Takeda, M. Kamioka, K. Ichikawa, T. Akiba, T. Arinami, and M. Shibasaki The Promoter Polymorphism in the Eosinophil Cationic Protein Gene and Its Influence on the Serum Eosinophil Cationic Protein Level Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 180 - 184. [Abstract] [Full Text] [PDF]

				J. Zhang and H. F. Rosenberg From the Cover: Complementary advantageous substitutions in the evolution of an antiviral RNase of higher primates PNAS, April 16, 2002; 99(8): 5486 - 5491. [Abstract] [Full Text] [PDF]

				J. Zhang and H. F. Rosenberg Diversifying Selection of the Tumor-Growth Promoter Angiogenin in Primate Evolution Mol. Biol. Evol., April 1, 2002; 19(4): 438 - 445. [Abstract] [Full Text] [PDF]

				J. Zhang and H. F. Rosenberg From the Cover: Complementary advantageous substitutions in the evolution of an antiviral RNase of higher primates PNAS, April 16, 2002; 99(8): 5486 - 5491. [Abstract] [Full Text] [PDF]